Medication-Attributable Adverse Events in Heart Failure Trials

By sjmartinez • March 8, 2023

Harrington J, Fonarow GC, Khan MS, Hernandez A, Anker S, Böhm M, Greene SJ, Felker GM, Vaduganathan M, Butler J. Medication-Attributable Adverse Events in Heart Failure Trials. JACC Heart Fail. 2023 Jan 12:S2213-1779(22)00721-1. doi: 10.1016/j.jchf.2022.11.026. Epub ahead of print. PMID: 36881395.

Tags: Adverse events, Cardiology/Epi, Guideline-directed medical therapy, heart failure, Publications

Effect of colchicine on progression of known coronary atherosclerosis in patients with stable coronary artery disease: EKSTROM randomized placebo controlled trial

Budoff MJ, Bhandari M, Iskander B, Ghanem AK, Kinninger A, Stark J, Garikapati V, Chilukuri S, Hankil V, Krishnan S, Punnanithinont N, Ichikawa K, Kambalapalli[...]

Potent P2Y12 Inhibitor Monotherapy Versus Dual Antiplatelet Therapy After Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Systematic Review and Meta-Analysis

Ibrahim M, Tariq S, Afridi MK, Zafar A, Khamisani FA, Aminpoor H, Arfin SMW, Fonarow GC, Greene SJ, Musani MH, Waqas SA. Potent P2Y12 Inhibitor[...]

Hemodynamics-driven magnetoelastic vascular grafts for stenosis diagnosis

Chen G, Chung T, Liu Z, Li YR, Scott K, Zhao X, Carol J, Park S, Zhou Y, Kim WJ, Ge X, Colby GP, Li[...]